Sign in
4

Changes in Ownership

Arcadia Biosciences, Inc. Filed Acc 0000950170-24-099605

Options or other derivatives

  • Chief Financial Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kawakami Mark · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-19 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,000 21,487 D
Loading xslF345X05/ownership.xml…